Metraipolis › archive › dc_13dcadb60211

Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation — Europe PMC PMID:41827827

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41827827
DOI: 10.3390/cells15050393
License (as archived): solo-consultazione
Archived: 2026-11-05T13:13:19.247Z
SHA-256 of the archived text: 84a43e0f9d43b0b136a0f426ef5f3decbd0a67e366e3401b8fd2f67a716e57c7
Stable URL of this page: https://metraipolis.com/documento/dc_13dcadb60211

How to cite

Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation — Europe PMC PMID:41827827 — Europe PMC (en), https://europepmc.org/article/MED/41827827 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13dcadb60211 (Metraipolis archive dc_13dcadb60211, sha256 84a43e0f9d43b0b136a0f426ef5f3decbd0a67e366e3401b8fd2f67a716e57c7)

BibTeX

@misc{dc13dcadb60211,
  title = {Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation — Europe PMC PMID:41827827},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41827827},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13dcadb60211; sha256 84a43e0f9d43b0b136a0f426ef5f3decbd0a67e366e3401b8fd2f67a716e57c7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827827. Agents can read the archived copy with the MCP tool read_document.